Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)

Tyler Mark Pierson, Thomas Markello, John Accardi, Lynne Wolfe, David Adams, Murat Sincan, Noor M. Tarazi, Karin Fuentes Fajardo, Praveen F. Cherukuri, Ilda Bajraktari, Katy G. Meilleur, Sandra Donkervoort, Mina Jain, Ying Hu, Tanya J. Lehky, Pedro Cruz, James C. Mullikin, Carsten Bonnemann, William A. Gahl, Cornelius F. BoerkoelCynthia J. Tifft

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Early-onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD) is a myopathic disorder associated with mutations in MEGF10. By novel analysis of SNP array hybridization and exome sequence coverage, we diagnosed a 10-years old girl with EMARDD following identification of a novel homozygous deletion of exon 7 in MEGF10. In contrast to previously reported EMARDD patients, her weakness was more prominent proximally than distally, and involved her legs more than her arms. MRI of her pelvis and thighs showed muscle atrophy and fatty replacement. Ultrasound of several muscle groups revealed dense homogenous increases in echogenicity. Cloning and sequencing of the deletion breakpoint identified features suggesting the mutation arose by fork stalling and template switching. These findings constitute the first genomic deletion causing EMARDD, expand the clinical phenotype, and provide new insight into the pattern and histology of its muscular pathology.

Original languageEnglish (US)
Pages (from-to)483-488
Number of pages6
JournalNeuromuscular Disorders
Volume23
Issue number6
DOIs
StatePublished - Jun 1 2013

Fingerprint

Exome
Muscular Diseases
Deglutition Disorders
Single Nucleotide Polymorphism
Exons
Mutation
Muscular Atrophy
Thigh
Pelvis
Organism Cloning
Leg
Histology
Arm
Pathology
Phenotype
Muscles

Keywords

  • Deletion analysis
  • EMARDD
  • Exome sequencing
  • MEGF10
  • Myopathy
  • SNP array

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Clinical Neurology
  • Genetics(clinical)

Cite this

Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD). / Pierson, Tyler Mark; Markello, Thomas; Accardi, John; Wolfe, Lynne; Adams, David; Sincan, Murat; Tarazi, Noor M.; Fajardo, Karin Fuentes; Cherukuri, Praveen F.; Bajraktari, Ilda; Meilleur, Katy G.; Donkervoort, Sandra; Jain, Mina; Hu, Ying; Lehky, Tanya J.; Cruz, Pedro; Mullikin, James C.; Bonnemann, Carsten; Gahl, William A.; Boerkoel, Cornelius F.; Tifft, Cynthia J.

In: Neuromuscular Disorders, Vol. 23, No. 6, 01.06.2013, p. 483-488.

Research output: Contribution to journalArticle

Pierson, TM, Markello, T, Accardi, J, Wolfe, L, Adams, D, Sincan, M, Tarazi, NM, Fajardo, KF, Cherukuri, PF, Bajraktari, I, Meilleur, KG, Donkervoort, S, Jain, M, Hu, Y, Lehky, TJ, Cruz, P, Mullikin, JC, Bonnemann, C, Gahl, WA, Boerkoel, CF & Tifft, CJ 2013, 'Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)', Neuromuscular Disorders, vol. 23, no. 6, pp. 483-488. https://doi.org/10.1016/j.nmd.2013.01.013
Pierson, Tyler Mark ; Markello, Thomas ; Accardi, John ; Wolfe, Lynne ; Adams, David ; Sincan, Murat ; Tarazi, Noor M. ; Fajardo, Karin Fuentes ; Cherukuri, Praveen F. ; Bajraktari, Ilda ; Meilleur, Katy G. ; Donkervoort, Sandra ; Jain, Mina ; Hu, Ying ; Lehky, Tanya J. ; Cruz, Pedro ; Mullikin, James C. ; Bonnemann, Carsten ; Gahl, William A. ; Boerkoel, Cornelius F. ; Tifft, Cynthia J. / Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD). In: Neuromuscular Disorders. 2013 ; Vol. 23, No. 6. pp. 483-488.
@article{5cd3b173d4ef4d628ff02d241a1d4c49,
title = "Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)",
abstract = "Early-onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD) is a myopathic disorder associated with mutations in MEGF10. By novel analysis of SNP array hybridization and exome sequence coverage, we diagnosed a 10-years old girl with EMARDD following identification of a novel homozygous deletion of exon 7 in MEGF10. In contrast to previously reported EMARDD patients, her weakness was more prominent proximally than distally, and involved her legs more than her arms. MRI of her pelvis and thighs showed muscle atrophy and fatty replacement. Ultrasound of several muscle groups revealed dense homogenous increases in echogenicity. Cloning and sequencing of the deletion breakpoint identified features suggesting the mutation arose by fork stalling and template switching. These findings constitute the first genomic deletion causing EMARDD, expand the clinical phenotype, and provide new insight into the pattern and histology of its muscular pathology.",
keywords = "Deletion analysis, EMARDD, Exome sequencing, MEGF10, Myopathy, SNP array",
author = "Pierson, {Tyler Mark} and Thomas Markello and John Accardi and Lynne Wolfe and David Adams and Murat Sincan and Tarazi, {Noor M.} and Fajardo, {Karin Fuentes} and Cherukuri, {Praveen F.} and Ilda Bajraktari and Meilleur, {Katy G.} and Sandra Donkervoort and Mina Jain and Ying Hu and Lehky, {Tanya J.} and Pedro Cruz and Mullikin, {James C.} and Carsten Bonnemann and Gahl, {William A.} and Boerkoel, {Cornelius F.} and Tifft, {Cynthia J.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1016/j.nmd.2013.01.013",
language = "English (US)",
volume = "23",
pages = "483--488",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)

AU - Pierson, Tyler Mark

AU - Markello, Thomas

AU - Accardi, John

AU - Wolfe, Lynne

AU - Adams, David

AU - Sincan, Murat

AU - Tarazi, Noor M.

AU - Fajardo, Karin Fuentes

AU - Cherukuri, Praveen F.

AU - Bajraktari, Ilda

AU - Meilleur, Katy G.

AU - Donkervoort, Sandra

AU - Jain, Mina

AU - Hu, Ying

AU - Lehky, Tanya J.

AU - Cruz, Pedro

AU - Mullikin, James C.

AU - Bonnemann, Carsten

AU - Gahl, William A.

AU - Boerkoel, Cornelius F.

AU - Tifft, Cynthia J.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Early-onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD) is a myopathic disorder associated with mutations in MEGF10. By novel analysis of SNP array hybridization and exome sequence coverage, we diagnosed a 10-years old girl with EMARDD following identification of a novel homozygous deletion of exon 7 in MEGF10. In contrast to previously reported EMARDD patients, her weakness was more prominent proximally than distally, and involved her legs more than her arms. MRI of her pelvis and thighs showed muscle atrophy and fatty replacement. Ultrasound of several muscle groups revealed dense homogenous increases in echogenicity. Cloning and sequencing of the deletion breakpoint identified features suggesting the mutation arose by fork stalling and template switching. These findings constitute the first genomic deletion causing EMARDD, expand the clinical phenotype, and provide new insight into the pattern and histology of its muscular pathology.

AB - Early-onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD) is a myopathic disorder associated with mutations in MEGF10. By novel analysis of SNP array hybridization and exome sequence coverage, we diagnosed a 10-years old girl with EMARDD following identification of a novel homozygous deletion of exon 7 in MEGF10. In contrast to previously reported EMARDD patients, her weakness was more prominent proximally than distally, and involved her legs more than her arms. MRI of her pelvis and thighs showed muscle atrophy and fatty replacement. Ultrasound of several muscle groups revealed dense homogenous increases in echogenicity. Cloning and sequencing of the deletion breakpoint identified features suggesting the mutation arose by fork stalling and template switching. These findings constitute the first genomic deletion causing EMARDD, expand the clinical phenotype, and provide new insight into the pattern and histology of its muscular pathology.

KW - Deletion analysis

KW - EMARDD

KW - Exome sequencing

KW - MEGF10

KW - Myopathy

KW - SNP array

UR - http://www.scopus.com/inward/record.url?scp=84878643262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878643262&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2013.01.013

DO - 10.1016/j.nmd.2013.01.013

M3 - Article

C2 - 23453856

AN - SCOPUS:84878643262

VL - 23

SP - 483

EP - 488

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 6

ER -